Ticker Details
Aytu BioScience, Inc. Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility.
IPO Date:	May 23, 2017
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$27.1M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 3.86%
Avg Daily Range (30 D):	$0.07 | 2.87%
Avg Daily Range (90 D):	$0.07 | 3.14%

Institutional Daily Volume
Avg Daily Volume:	1.48M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.14M

Trade Size
Avg Trade Size (Sh.):	439
Avg Trade Size (Sh.) (30 D):	171
Avg Trade Size (Sh.) (90 D):	202

Institutional Trades
Total Institutional Trades:	60
Avg Institutional Trade:	$1.63M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$.76M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.59M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	20.99K

News

Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A

Nov 15, 2023 @ 7:04 PM Why Shapeways Holdings Shares Are Trading Lower By... Source: Lisa Levin

Sep 28, 2023 @ 5:04 PM Why CarMax Shares Are Trading Lower By Around 10%?... Source: Lisa Levin

Sep 28, 2023 @ 3:55 PM Best Penny Stocks? 4 Hot Stocks With News This Wee... Source: J. Samuel

Aug 9, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Au... Source: Benzinga Insights

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.21	$-3.18	$-2.16
Diluted EPS	$-.08
Revenue	$13.89M	$15.14M	$66.38M
Gross Profit	$9.19M	$10.25M	$45.83M
Net Income / Loss	$1.97M	$-19.82M	$-13.56M
Operating Income / Loss	$-1.5M	$-7.62M	$-7.83M
Cost of Revenue	$4.7M	$4.88M	$20.55M
Net Cash Flow	$M	$12.78M	$10.95M
PE Ratio

Splits
Jan 06, 2023	1:20
Dec 09, 2020	1:10
Aug 13, 2018	1:20
Aug 29, 2017	1:20
Jul 01, 2016	1:12
Jun 10, 2015	11:134